Literature DB >> 17540083

Care takers' recall of Integrated Management of Childhood Illness counselling messages in Benin.

Jane M Kelly1, Alexander K Rowe, Faustin Onikpo, Marcel Lama, Francois Cokouits, Michael S Deming.   

Abstract

A key goal of the Integrated Management of Childhood Illness (IMCI) strategy is to improve the management of childhood illness at health facilities. IMCIguidelines contain many counselling messages, and as it is not known how well caretakers recall these messages, we studied caretakers' recall of IMCI messages when given under ideal conditions. At a clinic in Benin, a study clinician performed counselling and confirmed caretakers'comprehension of all messages. Caretakers were randomly assigned to be interviewed either immediately after the consultation or a day later. Recall was assessed with general and focused open-ended questions. Recall was assessed for 55 caretakers, 29.1% of whom were literate. Caretakers received 3-75 messages (mean = 38.7). The mean percentage of messages recalled was 89.7% immediately after the consultation and 81.9% one day later. These results support IMCI's recommendation that health workers should verify caretakers' comprehension by asking caretakers to repeat counselling messages during consultations.

Entities:  

Mesh:

Year:  2007        PMID: 17540083     DOI: 10.1177/004947550703700205

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  2 in total

1.  Training and capacity development: the foundation of interventions to support young children affected by HIV and AIDS in sub-Saharan Africa.

Authors:  Linda Richter; Julia Louw; Sara Naicker
Journal:  Vulnerable Child Youth Stud       Date:  2015-04-07

2.  Experiences of training and implementation of integrated management of childhood illness (IMCI) in South Africa: a qualitative evaluation of the IMCI case management training course.

Authors:  Christiane Horwood; Anna Voce; Kerry Vermaak; Nigel Rollins; Shamim Qazi
Journal:  BMC Pediatr       Date:  2009-10-01       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.